Emerging clinical applications of RNA

被引：250

作者：

Sullenger, BA ^{[1
]}

Gilboa, E ^{[1
]}

机构：

[1] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA

来源：

NATURE | 2002年 / 418卷 / 6894期

关键词：

D O I：

10.1038/418252a

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

RNA is a versatile biological macromolecule that is crucial in mobilizing and interpreting our genetic information. It is not surprising then that researchers have sought to exploit the inherent properties of RNAs so as to interfere with or repair dysfunctional nucleic acids or proteins and to stimulate the production of therapeutic gene products in a variety of pathological situations. The first generation of the resulting RNA therapeutics are now being evaluated in clinical trials, raising significant interest in this emerging area of medical research.

引用

收藏

页码：252 / 258

页数：7

相关论文

共 78 条

[1] A phase I trial of autologous CD34+ hematopoietic progenitor cells transduced with an anti-HIV ribozyme [J].

Amado, RG ;

Mitsuyasu, RT ;

Symonds, G ;

Rosenblatt, JD ;

Zack, J ;

Sun, LO ;

Miller, M ;

Ely, J ;

Gerlach, W .

HUMAN GENE THERAPY, 1999, 10 (13) :2255-+

[2] Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors [J].

Ashley, DM ;

Faiola, B ;

Nair, S ;

Hale, LP ;

Bigner, DD ;

Gilboa, E .

JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (07) :1177-1182

[3] Design of highly specific cytotoxins by using trans-splicing ribozymes [J].

Ayre, BG ;

Köhler, U ;

Goodman, HM ;

Haseloff, J .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) :3507-3512

[4] Dendritic cells and the control of immunity [J].

Banchereau, J ;

Steinman, RM .

NATURE, 1998, 392 (6673) :245-252

[5] Inhibition of human immunodeficiency virus-1 (HIV-1) replication after transduction of granulocyte colony-stimulating factor-mobilized CD34(+) cells from HIV-1-infected donors using retroviral vectors containing anti-HIV-1 genes [J].

Bauer, G ;

Valdez, P ;

Kearns, K ;

Bahner, I ;

Wen, SF ;

Zaia, JA ;

Kohn, DB .

BLOOD, 1997, 89 (07) :2259-2267

[6] CHEMICAL MODIFICATION OF HAMMERHEAD RIBOZYMES - CATALYTIC ACTIVITY AND NUCLEASE RESISTANCE [J].

BEIGELMAN, L ;

MCSWIGGEN, JA ;

DRAPER, KG ;

GONZALEZ, C ;

JENSEN, K ;

KARPEISKY, AM ;

MODAK, AS ;

MATULICADAMIC, J ;

DIRENZO, AB ;

HAEBERLI, P ;

SWEEDLER, D ;

TRACZ, D ;

GRIMM, S ;

WINCOTT, FE ;

THACKRAY, VG ;

USMAN, N .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (43) :25702-25708

[7] SELECTION OF SINGLE-STRANDED-DNA MOLECULES THAT BIND AND INHIBIT HUMAN THROMBIN [J].

BOCK, LC ;

GRIFFIN, LC ;

LATHAM, JA ;

VERMAAS, EH ;

TOOLE, JJ .

NATURE, 1992, 355 (6360) :564-566

[8]

Boczkowski D, 2000, CANCER RES, V60, P1028

[9] Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo [J].

Boczkowski, D ;

Nair, SK ;

Snyder, D ;

Gilboa, E .

JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :465-472

[10]

CECH TR, 1988, JAMA-J AM MED ASSOC, V260, P3030

← 1 2 3 4 5 6 7 8 →